| Product Code: ETC12923503 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Androgen Insensitivity Syndrome Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Androgen Insensitivity Syndrome Market - Industry Life Cycle |
3.4 Israel Androgen Insensitivity Syndrome Market - Porter's Five Forces |
3.5 Israel Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Symptoms, 2021 & 2031F |
3.6 Israel Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Androgen Insensitivity Syndrome Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Androgen Insensitivity Syndrome Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Israel Androgen Insensitivity Syndrome Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about androgen insensitivity syndrome (AIS) among healthcare professionals and patients in Israel. |
4.2.2 Advances in medical research leading to the development of new treatment options for AIS. |
4.2.3 Growing government initiatives and support for rare disease treatment and research in Israel. |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare professionals with expertise in managing AIS in Israel. |
4.3.2 High cost of treatment and medications for AIS patients. |
4.3.3 Lack of standardized protocols and guidelines for the diagnosis and management of AIS in Israel. |
5 Israel Androgen Insensitivity Syndrome Market Trends |
6 Israel Androgen Insensitivity Syndrome Market, By Types |
6.1 Israel Androgen Insensitivity Syndrome Market, By Symptoms |
6.1.1 Overview and Analysis |
6.1.2 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Symptoms, 2021 - 2031F |
6.1.3 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Undescended Testes, 2021 - 2031F |
6.1.4 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Inguinal Herni Physical Examination, 2021 - 2031F |
6.1.5 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Lack of Pubic Hair, 2021 - 2031F |
6.2 Israel Androgen Insensitivity Syndrome Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.3 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Psychological Support, 2021 - 2031F |
6.2.4 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Endocrine Evaluation, 2021 - 2031F |
6.3 Israel Androgen Insensitivity Syndrome Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Hormone Replacement Therapy, 2021 - 2031F |
6.3.3 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Gonadectomy, 2021 - 2031F |
6.4 Israel Androgen Insensitivity Syndrome Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By linics, 2021 - 2031F |
6.4.4 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Topical, 2021 - 2031F |
6.5 Israel Androgen Insensitivity Syndrome Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Retail Pharmacy, 2021 - 2031F |
6.5.4 Israel Androgen Insensitivity Syndrome Market Revenues & Volume, By Others, 2021 - 2031F |
7 Israel Androgen Insensitivity Syndrome Market Import-Export Trade Statistics |
7.1 Israel Androgen Insensitivity Syndrome Market Export to Major Countries |
7.2 Israel Androgen Insensitivity Syndrome Market Imports from Major Countries |
8 Israel Androgen Insensitivity Syndrome Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in AIS management in Israel. |
8.2 Patient satisfaction rates with the quality of AIS care received. |
8.3 Research and development investments in AIS treatment options in Israel. |
9 Israel Androgen Insensitivity Syndrome Market - Opportunity Assessment |
9.1 Israel Androgen Insensitivity Syndrome Market Opportunity Assessment, By Symptoms, 2021 & 2031F |
9.2 Israel Androgen Insensitivity Syndrome Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Androgen Insensitivity Syndrome Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Androgen Insensitivity Syndrome Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Androgen Insensitivity Syndrome Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Israel Androgen Insensitivity Syndrome Market - Competitive Landscape |
10.1 Israel Androgen Insensitivity Syndrome Market Revenue Share, By Companies, 2024 |
10.2 Israel Androgen Insensitivity Syndrome Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here